These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29961201)

  • 1. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients.
    Tomic S; Pekic V; Popijac Z; Pucic T; Vinkovic MP; Kuric TG; Popovic Z
    Neurol Sci; 2018 Oct; 39(10):1691-1695. PubMed ID: 29961201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What increases the risk of malnutrition in Parkinson's disease?
    Tomic S; Pekic V; Popijac Z; Pucic T; Petek M; Kuric TG; Misevic S; Kramaric RP
    J Neurol Sci; 2017 Apr; 375():235-238. PubMed ID: 28320137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum homocysteine and physical exercise in patients with Parkinson's disease.
    Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
    Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level.
    Shin HW; Sohn YH
    J Mov Disord; 2009 May; 2(1):33-6. PubMed ID: 24868350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of characteristics affecting instrumental activities of daily living in Parkinson's disease patients without dementia.
    Choi SM; Yoon GJ; Jung HJ; Kim BC
    Neurol Sci; 2019 Jul; 40(7):1403-1408. PubMed ID: 30931509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Hyperhomocysteinemia on Motor Symptoms, Cognitive Status, and Vascular Risk in Patients with Parkinson's Disease.
    Kocer B; Guven H; Conkbayir I; Comoglu SS; Delibas S
    Parkinsons Dis; 2016; 2016():1589747. PubMed ID: 27642535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.
    O'Suilleabhain PE; Sung V; Hernandez C; Lacritz L; Dewey RB; Bottiglieri T; Diaz-Arrastia R
    Arch Neurol; 2004 Jun; 61(6):865-8. PubMed ID: 15210523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional Status Associated with Molecular Biomarkers, Physiological Indices, and Clinical Severity in Parkinson's Disease Patients.
    Lin TK; Chang YY; Chen NC; Liou CW; Lan MY; Chen YF; Tsai CL
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.
    Zhang L; Yan J; Xu Y; Long L; Zhu C; Chen X; Jiang Y; Yang L; Bian L; Wang Q
    PLoS One; 2011 Apr; 6(4):e19333. PubMed ID: 21556377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between malnutrition, clinical parameters and health-related quality of life in elderly hospitalized patients with Parkinson's disease: A cross-sectional study.
    Gruber MT; Witte OW; Grosskreutz J; Prell T
    PLoS One; 2020; 15(5):e0232764. PubMed ID: 32365092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine Levels in Parkinson's Disease: Is Entacapone Effective?
    Kocer B; Guven H; Comoglu SS
    Biomed Res Int; 2016; 2016():7563705. PubMed ID: 27493964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.
    Hassin-Baer S; Cohen O; Vakil E; Sela BA; Nitsan Z; Schwartz R; Chapman J; Tanne D
    Clin Neuropharmacol; 2006; 29(6):305-11. PubMed ID: 17095893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression features of serum Cystatin C and homocysteine of Parkinson's disease with mild cognitive dysfunction.
    Chen WW; Cheng X; Zhang X; Zhang QS; Sun HQ; Huang WJ; Xie ZY
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):2957-63. PubMed ID: 26367713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and nutritional correlations in Parkinson's disease: Preliminary report.
    Budrewicz S; Zmarzły A; Rączka D; Szczepańska A; Koziorowska-Gawron E; Słotwiński K; Koszewicz M
    Adv Clin Exp Med; 2019 Feb; 28(2):193-198. PubMed ID: 29963785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.
    dos Santos EF; Busanello EN; Miglioranza A; Zanatta A; Barchak AG; Vargas CR; Saute J; Rosa C; Carrion MJ; Camargo D; Dalbem A; da Costa JC; de Sousa Miguel SR; de Mello Rieder CR; Wajner M
    Metab Brain Dis; 2009 Jun; 24(2):257-69. PubMed ID: 19294496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
    Camicioli RM; Bouchard TP; Somerville MJ
    Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Hypovitaminosis D and Nutritional Status with The Severity of Clinical Symptoms And Impaired Cognitive Function in Patients with Parkinson's Disease.
    Lien CY; Lu CH; Chang CC; Chang WN
    Acta Neurol Taiwan; 2021 Jun; 30(2)():63-73. PubMed ID: 34549391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.